Results 221 to 230 of about 10,256,810 (359)

Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers. [PDF]

Am J Health Syst Pharm
Loubet P, Chandak A, Spivey S, Doi Y, Amin AN, Ahuja N, Müller V, Sax PE.   +7 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Enhancing professional adaptability and clinical soft skills of new clinical pharmacists through a pre-training model in China: a randomized controlled trial. [PDF]

BMC Med Educ
Wang T, Liang J, Chen L, Li S, Zhu M, Cai Y, Chen M.   +6 more
europepmc   +1 more source

Clinical Pharmacist and Telemonitoring [PDF]

Journal of Pharmacy and Pharmaceutics, 2014
openaire   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Design and evaluation of a comprehensive training program for hospital-based clinical pharmacists - various, active, and work-integrated learning. [PDF]

Explor Res Clin Soc Pharm
Lea M, Trapnes E, Steen H, Ødegaard NB.
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety-a case report. [PDF]

J Med Case Rep
Chen W, Wang D, Fu W, Wang J, Chen M, Li J, Li F.   +6 more
europepmc   +1 more source

"Clinical" and "administrative" pharmacists. [PDF]

BMJ, 1971
openaire   +2 more sources

Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review

DARU Journal of Pharmaceutical Sciences, 2019
A. Noormandi, I. Karimzadeh, Mahtabalsadat Mirjalili, H. Khalili   +3 more
semanticscholar   +1 more source